Understanding the vaginal microbiome's role in preterm birth
Quantitative Metagenomics and the Vaginal Microbiome of Preterm Birth
This study is looking at how the bacteria in the vagina of pregnant women might affect the chances of having a baby too early, and it's working on better ways to analyze this bacteria so that doctors can spot any risks more accurately and help keep moms and babies healthy.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | North Carolina State University Raleigh NIH-funded |
| Lab location | 1 site (Raleigh, United States) |
| Project ID | NIH-10673943 on NIH RePORTER |
What this research studies
This research focuses on improving the methods used to analyze the vaginal microbiome of pregnant women, particularly how it relates to the risk of preterm birth. The team develops advanced computational techniques to enhance the accuracy of microbiome sequencing, allowing for a better understanding of the microbial communities present. By addressing biases in current sequencing methods, the research aims to provide clearer insights into how these microbial populations may influence pregnancy outcomes. Patients may benefit from improved diagnostic tools that could identify risks associated with preterm birth.
Who could benefit from this research
Good fit: Ideal candidates for this research are pregnant women, particularly those at risk of preterm birth or with concerns about their vaginal microbiome.
Not a fit: Patients who are not pregnant or those who have already delivered their babies may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to better predictive tools for assessing the risk of preterm birth in pregnant women.
How similar studies have performed: Previous research has shown promising results in understanding the vaginal microbiome's impact on pregnancy outcomes, indicating that this approach has potential for success.
Where this research is happening
Raleigh, United States
- North Carolina State University Raleigh — Raleigh, United States (Active)
Researchers
- Principal investigator: Callahan, Benjamin John — North Carolina State University Raleigh
- Study coordinator: Callahan, Benjamin John
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.